Clinical Trials Browser

OTHER × Interventional × Solid Tumor × Clear all

NCT04381806 2026-05-22

Phase I Study in Advanced Malignancies With 5-ALA

Phase 1 Suspended

Other solid neoplasm

Solid Tumor

NCT05206942 2026-05-06

Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy

Phase NA Suspended

Other solid neoplasm

Solid Tumor

NCT05645523 2026-05-04

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06349837 2026-05-01

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07556276 2026-04-29

Study of CMTS1215 Injection in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT03810339 2026-04-23

Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT03447483 2026-04-14

MOTIVATE

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT06383598 2026-04-07

PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT05238792 2026-03-12

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06563375 2026-03-12

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05661201 2026-03-06

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05436093 2026-03-04

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT04469530 2026-02-27

AflacST1903

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05100251 2026-02-17

Clinical Trial of WBC100 on Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT07225088 2026-01-26

DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT03875287 2026-01-12

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT05522491 2025-12-11

Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT05525767 2025-12-11

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Phase 4 Recruiting

Other solid neoplasm

Solid Tumor

NCT04276376 2025-12-01

ARIANES

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT04942717 2025-11-26

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06310655 2025-11-10

PARTy

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT01239381 2025-09-30

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase NA Completed

92 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02992210 2025-09-08

Study on GD2 Positive Solid Tumors by 4SCAR-GD2

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07107633 2025-08-06

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06894745 2025-07-22

PET [89Zr]DFO-starPEG in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06443710 2025-07-15

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05301101 2025-06-29

REDIRICT

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT06883149 2025-06-10

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT02608385 2025-06-08

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase 2 Terminated

2 enrolled 4 charts

Other solid neoplasm

Solid Tumor

NCT03839342 2025-02-03

BEAVER

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06541301 2024-11-19

PICCHEST

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04185831 2024-08-22

MEGALiT

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT06429891 2024-08-22

Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT04422457 2024-08-19

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT06537505 2024-08-05

A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT06394622 2024-05-01

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06101082 2024-03-06

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT03905538 2024-03-01

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Phase EARLY_PHASE1 Withdrawn

Other solid neoplasm

Solid Tumor

NCT04552418 2024-02-28

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT04071756 2024-02-07

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Phase 2 Terminated

8 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT05576961 2024-01-23

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor